Coeptis Therapeutics Inc. Quarterly Cost of Revenue in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Coeptis Therapeutics Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2020 to Q3 2022.
  • Coeptis Therapeutics Inc. Cost of Revenue for the quarter ending September 30, 2022 was $0.000.
  • Coeptis Therapeutics Inc. Cost of Revenue for the twelve months ending September 30, 2022 was $0.000, a 100% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Cost of Revenue for 2021 was $0.000, a 100% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $0 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $0 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 $0 -$961K -100% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $961K $0 -$1.49K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $962K $0 -$1.87K -100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $964K $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $964K $961K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $1.49K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $1.87K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.